1 | prior | 17,973 |
2 | prebaseline | 4 |
3 | -13.13 | 2 |
4 | 5957 | 2 |
5 | bone-volume | 2 |
6 | cosensitization | 2 |
7 | sugammadex/neostigmine | 2 |
8 | up-ramp | 2 |
9 | ≥one | 2 |
10 | -3.503 | 1 |
11 | 1/6/2008 | 1 |
12 | 1955-1997 | 1 |
13 | 1992/1993 | 1 |
14 | 40/94 | 1 |
15 | 40/95 | 1 |
16 | bacteria/carcass | 1 |
17 | contradindications | 1 |
18 | controlled-posture | 1 |
19 | down-ramp | 1 |
20 | effect-needed | 1 |
21 | expectation/preference | 1 |
22 | gain-and-loss-of-function | 1 |
23 | group.two | 1 |
24 | nonrandomized/retrospective | 1 |
25 | ofage-admitted | 1 |
26 | post-net | 1 |
27 | postadjuvant | 1 |
28 | postfellowship | 1 |
29 | postovariectomy | 1 |
30 | poststatic | 1 |
31 | post‑ovx | 1 |
32 | prescribed.further | 1 |
33 | re-parameterization | 1 |
34 | speed/contemporary | 1 |
35 | this.relative | 1 |
36 | workplace/employer | 1 |
1 | -13.13 | 2 |
2 | -3.503 | 1 |
3 | 1/6/2008 | 1 |
4 | 1955-1997 | 1 |
5 | 1992/1993 | 1 |
6 | 40/94 | 1 |
7 | 40/95 | 1 |
8 | 5957 | 2 |
9 | bacteria/carcass | 1 |
10 | bone-volume | 2 |
11 | contradindications | 1 |
12 | controlled-posture | 1 |
13 | cosensitization | 2 |
14 | down-ramp | 1 |
15 | effect-needed | 1 |
16 | expectation/preference | 1 |
17 | gain-and-loss-of-function | 1 |
18 | group.two | 1 |
19 | nonrandomized/retrospective | 1 |
20 | ofage-admitted | 1 |
21 | post-net | 1 |
22 | postadjuvant | 1 |
23 | postfellowship | 1 |
24 | postovariectomy | 1 |
25 | poststatic | 1 |
26 | post‑ovx | 1 |
27 | prebaseline | 4 |
28 | prescribed.further | 1 |
29 | prior | 17,973 |
30 | re-parameterization | 1 |
31 | speed/contemporary | 1 |
32 | sugammadex/neostigmine | 2 |
33 | this.relative | 1 |
34 | up-ramp | 2 |
35 | workplace/employer | 1 |
36 | ≥one | 2 |
1 | -3.503 | 1 |
2 | -13.13 | 2 |
3 | 1992/1993 | 1 |
4 | 40/94 | 1 |
5 | 40/95 | 1 |
6 | 5957 | 2 |
7 | 1955-1997 | 1 |
8 | 1/6/2008 | 1 |
9 | poststatic | 1 |
10 | effect-needed | 1 |
11 | ofage-admitted | 1 |
12 | expectation/preference | 1 |
13 | bone-volume | 2 |
14 | prebaseline | 4 |
15 | sugammadex/neostigmine | 2 |
16 | ≥one | 2 |
17 | controlled-posture | 1 |
18 | this.relative | 1 |
19 | nonrandomized/retrospective | 1 |
20 | re-parameterization | 1 |
21 | cosensitization | 2 |
22 | gain-and-loss-of-function | 1 |
23 | group.two | 1 |
24 | postfellowship | 1 |
25 | down-ramp | 1 |
26 | up-ramp | 2 |
27 | prescribed.further | 1 |
28 | workplace/employer | 1 |
29 | prior | 17,973 |
30 | contradindications | 1 |
31 | bacteria/carcass | 1 |
32 | post-net | 1 |
33 | postadjuvant | 1 |
34 | post‑ovx | 1 |
35 | postovariectomy | 1 |
36 | speed/contemporary | 1 |